OBJECTIVE： To investigate ADR induced by dasatinib， and to provide reference for clinical rational drug use. METHODS： By means of literature metrology method， dasatinib-induced ADR cases domestically and internationally reported were analyzed. RSEULTS： A total of 63 ADR cases were induced by dasatinib， and the age of patients were mainly 41-60 years old. The most cases （25.4％） occurred within 1 month of medication. The patients mainly were from Asian countries and regions （53.9％）. Organs/systems involved in dasatinib induced ADRs were mainly respiratory system （40.1％），digestive system （17.5％） and hematologic system （11.7％）. Main clinical manifestations were pleural effusion （23 cases）， pulmonary artery hypertension （15 cases）， expiratory dyspnea （8 cases）， diarrhea （8 cases）， etc. CONCLUSIONS： Daring the use of dasatinib， great importance should be attached to ADR monitoring and prevention so as to avoid serious ADR.